World Markets Simplified

Below is the detailed news from Reuters:

Temple-Inland Inc. announced that it has declared a dividend distribution of one Preferred Share Purchase Right on each outstanding share of Temple-Inland common stock. The Rights will be exercisable only if a person or group acquires 10% or more of Temple-Inland’s common stock. Each Right will entitle stockholders to buy one one-hundredth of a share of a new series of junior participating preferred stock at an exercise price of $120. The dividend distribution will be made on June 17, 2011, payable to stockholders of record as of the close of business on that date, and is not taxable to stockholders. The Rights will expire on June 7, 2016.

When you're logged in to LinkedIn, take a tour of a new-ish feature called Signal. This tool lets you easily monitor updates within your network, but more importantly you can filter information so you can also see what people in your extended circle (2nd and 3rd connections) are posting. You can also do the same filtering by industry or location, so you can weed through the noise.

Go to "My Connections" to view a list of all your LinkedIn contacts. This address book is a really handy way to get email addresses and updated information, but most importantly you can export this list. At the bottom of the page click "Export Connections," which will put all this contact info in a format suitable for your address book (Microsoft Outlook, Yahoo! Mail, etc.).

If you've already filled out your LinkedIn profile information, it's easy to use it to create a foundation for a resume. The Resume Builder will suck in your professional past and you can use any of the pre-built templates to make it look good. From an Executive style presentation to a more casual layout, this tool will take some of the pain out of the resume building process. You can export the resume, share it easily, and edit as you wish.

While, unlike Twitter, you might not find celebrities hanging out, you will find a wealth of relevant conversations within LinkedIn groups. Creating a group is a cinch and a great opportunity to jump-start a good business chat. If you don't know what group to join, click on "Groups You May Like" to get you started. To learn more about the benefits of Groups and what LinkedIn has planned for this feature in the future, visit their online tutorial.

Custom domain names have been all the rage for a while on Facebook, but you can do the same on LinkedIn. Visit the "Edit Profile" tab and click "Public Profile" at bottom left. Once you're on this page, on the far right you will see "Your current URL." This is where you can customize your LinkedIn domain name so you can better brand your account.

( Source: Fast Company )

Tuesday, Reserve bank of Australia announced unchanged interest rate at 4.75 percent, leaving a policy unchanged rather than tightening as expected by some analysts' to curb inflation.

In a brief statement after its monthly policy meeting, the Reserve Bank of Australia (RBA) said only that rates were appropriate given the economic outlook. That was a change from its monetary policy outlook in May when it said a further tightening would likely be needed.

Markets had priced in only a small chance of a hike at this meeting and the statement led them to trim the risk of a move in July or August. The central bank has led the developed world in lifting rates by 175 basis points since late 2009.

The Australian dollar slipped almost half a U.S. cent as the statement was not as hawkish as some had bet on. Interbank futures rallied as the market scaled back the chances of a hike in the next few months as well.

( Source: Reuters )

Hookahs could go the way of cigarettes, cigars and pipes if Utah health officials approve a ban on smoking heated tobacco in popular bars and other public places.

Health officials argue secondhand smoke from hookahs is just as dangerous as that of other tobacco products, which state law already prohibits in public indoor spaces. That includes all bars.

"There are harmful effects from the secondhand smoke from hookahs," Utah Department of Public Health spokesman Steve Hadden said Monday. "Just because it's an adult place doesn't mean it's any less harmful."

Two Utah counties have banned hookah smoking in public, although neither county had any businesses that offered hookahs at the time of the bans. Other public health officials have asked the state for a clarification about whether smoking hookahs, in which tobacco is sometimes mixed with flavorings, violates the indoor smoking laws.

The ban would not prohibit hookahs outright, only tobacco in the hookahs, Hadden said. There are non-tobacco options available and those would still be legal.

There are a number of bars and restaurants that offer hookahs in the state, primarily in Salt Lake City and surrounding suburbs. They include sushi bars, Middle Eastern restaurants and social clubs.

In its proposed rule, the health department acknowledges the ban could severely impact businesses where hookah smoking is a primary attraction.

Nathan Porter, the owner of the Huka Bar, said the ban would potentially ruin his business.

"We're called the Huka Bar," Porter told Fox 13. "People come here knowing we have hookahs or they're with their friends who smoke hookah."

A public hearing was held for the hookah ban Monday afternoon in Salt Lake City.

During debates last year in Davis County, which was the first county to ban hookahs, health director Lewis Garrett said hookah smoke is still smoke that can be harmful to people.

"One of the reasons this is so prevalent, is it smells good," Garrett said. "It doesn't smell like tobacco. It smells like incense or something flavorful. And I think there's a misconception that this isn't nearly as harmful as cigarettes because it's filtered through the water and it smells nice."

Copyright 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

After the issue of hacking of a game network, Sony came up with a new handheld device called Playstation Vita for this holiday season. Earlier company was in the news as its online network was repetitively hacked by some unknown hackers and customers private information were stolen from the network. Sony had to shut down its network for almost a month because of these issues.

The new PlayStation Vita will go on sale for $249, or $299 for a 3G mobile version, starting in the holiday season, the Japanese electronics giant's No. 2 executive Kazuo Hirai told reporters on the eve of the E3 games convention. Playstation Vita device will work with exclusive AT&T carrier for network that some users  might don't like it, as many users using Apple's iPhones have complains about the poor connectivity of AT&T network.

The upbeat presentation was a far cry from Hirai's last public appearance, a May 1 news conference in Tokyo at which he bowed deeply and repeatedly to show the company's contrition after data on tens of millions of user accounts was stolen by hackers.

The company just managed to restore the PlayStation Network in full in its main North American and European markets ahead of E3, which runs from June 7-9.

Jack Tretton, the head of the company's U.S. videogames division, told reporters activity on the network was back up to 90 percent of what it had been before the security breach and that last week's PlayStation sales were up 27 percent on last year.

Restoring services quickly was seen as essential because connectivity is one of the main selling points of the Vita.

For serious gamers, the ability to take up games where they left off, even while they are are away from home, could be a key differentiation point from main rival Microsoft, which does not offer a portable device.

The global games market is expected to grow to $65 billion this year, up from $62.7 billion in 2010.

( Source: Reuters )

• Generex Biotechnology Corporation (GNBT) Announces Mutual Decision Not to Proceed with Global Medical Direct Acquisition More... 

• Emergent BioSolutions (EBS) Acquires Late-Stage Monoclonal Antibody Cancer Therapy from TenX Biopharma More...

• Biomedical Advanced Research and Development Authority (BARDA) Exercises Options With Cangene Corporation (CC:CNJ) Worth US$61 Million Under Botulism Antitoxin Supply Contract More...

• Cellectis BioResearch and VitamFero Collaborate to Develop Vaccines against Parasitic Infection More... 

• Waters Corporation (WAT) and PREMIER Biosoft International Announce Collaboration for Advancing Lipidomics Research More...

 

• GTx, Inc. (GTXI) Announces Agreement with FDA on Phase III Clinical Development Plan Evaluating Ostarine(TM) (GTx-024) for the Prevention and Treatment of Muscle Wasting in Patients with Non-Small Cell Lung Cancer More... 

• Elite Pharmaceuticals, Inc. (ELI) Announces Manufacturing and Supply Agreement With Mikah Pharma, LLC More...

• AVI BioPharma, Inc. (AVII) Names Ed Kaye, M.D., Chief Medical Officer More... 

• FibroGen, Inc. Appoints R. Wayne Frost, Pharm.D., J.D., Vice President of Regulatory Affairs More...

• Bristol-Myers Squibb Company (BMY) Promotes Chad Ronholdt to VP of Strategic Development More... 

• Grifols Announces the Appointment of Thomas Glanzmann as Chairman of its New Board of Directors for U.S. Operations More... 

• Dr. David Kaplan Joins Kraig Biocraft Laboratories, Inc. Scientific Advisory Board More...

• Tikcro Technologies Reports 2011 First Quarter Results More...

• Johnson & Johnson (JNJ) Unit Ortho-McNeil-Janssen Pharmaceuticals, Inc. Ordered to Pay Record Breaking $327 Million Over Deceptive Risperdal Marketing Claims More...

 

• Tekmira Pharmaceuticals Corporation Files Amended Complaint in Alnylam Pharmaceuticals (ALNY) Litigation More...

• InfoMedics, Inc. Expands in Europe, Latin America and Asia-Pacific More...

• Roche (RHHBY) Melanoma Drug Cuts Risk Of Death By 63 Percent; Bests Bristol-Myers Squibb Company (BMY) In Study More... 

• Pfizer Inc. (PFE)'s Aromasin Blocks Breast Cancer in Healthy, At-Risk Women in Study More... 

• Ariad Pharmaceuticals, Inc. (ARIA) and Merck & Co., Inc. (MRK)'s Cancer Drug for Bones-Tissue Extends Patient Lives in Study More... 

• Pfizer Inc. (PFE) Lung Cancer Pill May Double Survival More... 

• United Therapeutics Corporation (UTHR)'s FREEDOM-M Phase 3 Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint More...

• American Regent, Inc. Initiates Nationwide Voluntary Recall of Methyldopate HCL Injection, USP 5 mL Single Dose Vial Due to Glass Particulates More...

• Incyte Corporation (INCY) Submits New Drug Application for Ruxolitinib in Myelofibrosis to the US FDA More...

• Finally, a Pill for Men 'With No Side-Effects' Which Could be on the Shelves in a Few Years Columbia University Study More... 

• New Generation Asthma Drug Could Improve Metabolism, Garvan Institute of Medical Research Research Suggests More... 

• Epilepsy Drugs' Risk of Birth Defects May Be Dose-Dependent, Karolinska Institute Study More... 

• Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects More... 

• Ipsen Announces Discontinuation of the Development of Irosustat in Monotherapy More...

Daily Digest Stockinvestips